21 Jul 2009
Second quarter 2009 results date notification – August 5, 2009
21 Jul 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce second quarter 2009 earnings on Wednesday August 5, 2009.
Results press release will be issued at: 12:00 BST / 07:00 EDT
Conference call time: 14:00 BST / 09:00 EDT
Angus Russell, Chief Executive Officer and Graham Hetherington, Chief Financial Officer will host the quarterly results presentation call at 14:00 BST/9:00 EDT.
The details of the conference call are as follows:
UK dial in: 0808 100 5150 or 01296 311 652
US dial in: 1 8662977327 or 1 7183541176
International dial in: +44 (0) 1296 311 652
Password/Conf ID: 515 749#
Live Webcast: http://www.shire.com/shire/InvestorRelations/index.jsp?tn=2
A replay of the conference call will be available by phone for two weeks and on our website for 12 months. For further information; please visit our Investor Relations’ website. http://www.shire.com/shire/InvestorRelations/index.jsp?tn=2 .
For further information please contact:
Souheil Salah (Rest of the World) +44 1256 894 160
Ricki Greenwood (North America) +1 484 595 8517
Notes to editors
Shire’s strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire’s in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.
For further information on Shire, please visit the Company’s website: www.shire.com.